HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

ReCAP: Impact of Multidisciplinary Care on Processes of Cancer Care: A Multi-Institutional Study.

AbstractPURPOSE:
The role of multidisciplinary care (MDC) on cancer care processes is not fully understood. We investigated the impact of MDC on the processes of care at cancer centers within the National Cancer Institute Community Cancer Centers Program (NCCCP).
METHODS:
The study used data from patients diagnosed with stage IIB to III rectal cancer, stage III colon cancer, and stage III non–small-cell lung cancer at 14 NCCCP cancer centers from 2007 to 2012. We used an MDC development assessment tool—with levels ranging from evolving MDC (low) to achieving excellence (high)—to measure the level of MDC implementation in seven MDC areas, such as case planning and physician engagement. Descriptive statistics and cluster-adjusted regression models quantified the association between MDC implementation and processes of care, including time from diagnosis to treatment receipt.
RESULTS:
A total of 1,079 patients were examined. Compared with patients with colon cancer treated at cancer centers reporting low MDC scores, time to treatment receipt was shorter for patients with colon cancer treated at cancer centers reporting high or moderate MDC scores for physician engagement (hazard ratio [HR] for high physician engagement, 2.66; 95% CI, 1.70 to 4.17; HR for moderate physician engagement, 1.50; 95% CI, 1.19 to 1.89) and longer for patients with colon cancer treated at cancer centers reporting high 2MDC scores for case planning (HR, 0.65; 95% CI, 0.49 to 0.85). Results for patients with rectal cancer were qualitatively similar, and there was no statistically significant difference among patients with lung cancer.
CONCLUSION:
MDC implementation level was associated with processes of care, and direction of association varied across MDC assessment areas.
AuthorsEberechukwu Onukwugha, Nicholas J Petrelli, Kathleen M Castro, James F Gardner, Jinani Jayasekera, Olga Goloubeva, Ming T Tan, Erica J McNamara, Howard A Zaren, Thomas Asfeldt, James D Bearden 3rd, Andrew L Salner, Mark J Krasna, Irene Prabhu Das, Steve B Clauser, Eberechukwu Onukwugha, Nicholas J Petrelli, Kathleen M Castro, James F Gardner, Jinani Jayasekera, Olga Goloubeva, Ming T Tan, Erica J McNamara, Howard A Zaren, Thomas Asfeldt, James D Bearden 3rd, Andrew L Salner, Mark J Krasna, Irene Prabhu Das, Steve B Clauser
JournalJournal of oncology practice (J Oncol Pract) Vol. 12 Issue 2 Pg. 155-6; e157-68 (Feb 2016) ISSN: 1935-469X [Electronic] United States
PMID26464497 (Publication Type: Journal Article, Multicenter Study, Research Support, N.I.H., Extramural)
CopyrightCopyright © 2015 by American Society of Clinical Oncology.
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Cancer Care Facilities
  • Combined Modality Therapy
  • Female
  • Guideline Adherence
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Neoplasms (diagnosis, epidemiology, therapy)
  • Patient Care (methods, standards)
  • Patient Care Planning
  • Patient Care Team
  • Prospective Studies
  • Retrospective Studies
  • Time-to-Treatment
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: